Workshop_in_brief
Artificial intelligence (AI) and automation are increasingly being used to aid biological discovery and biotechnology development. Robotic and remotely controlled equipment is being used to accelerate research, while AI is opening new opportunities to explore the natural world and inform efforts to build biological entities with useful capabilities. Such technologies are poised to drive beneficial advances in health, biomaterials, environmental remediation, biomanufacturing, agriculture, and other areas. However, these developments also raise new questions and potential risks. Researchers, policymakers, and the public have sought to examine how applying AI and automation in biotechnology might lead to new challenges for biosecurity, health and safety, the environment, the integrity of scientific data, and economic development and national competitiveness.
To examine these issues, the National Academies of Sciences, Engineering, and Medicine hosted a workshop titled Artificial Intelligence and Automated Laboratories for Biotechnology: Leveraging Opportunities and Mitigating Risks, on April 3-4, 2024. Participants from government, academia, nonprofit organizations, and private industry communities gathered virtually and in person to explore the use of AI and automation in biological research and development; discuss considerations relevant to national security; and share perspectives on potential future pathways for technology and policy development. This Proceedings of a Workshop-in Brief provides the rapporteurs' high-level overview of the event.
12 pages
·
8.5 x 11
·
ISBN Ebook: 0-309-71541-5
DOI:
https://doi.org/10.17226/27469
National Academies of Sciences, Engineering, and Medicine. 2024. Artificial Intelligence and Automated Laboratories for Biotechnology: Leveraging Opportunities and Mitigating Risks: Proceedings of a Workshop—in Brief. Washington, DC: The National Academies Press.
Import this citation to: